Mesa Laboratories Inc (MLAB)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 437,148 454,098 440,361 446,796 741,769 637,188 642,611 661,832 662,984 656,231 685,811 707,369 721,712 609,102 612,490 600,151 621,636 588,932 576,733 420,206
Total stockholders’ equity US$ in thousands 155,214 161,451 150,727 145,393 402,961 387,759 387,719 393,480 387,205 374,236 380,431 393,801 396,329 399,417 399,003 406,227 412,795 392,412 382,234 220,013
Financial leverage ratio 2.82 2.81 2.92 3.07 1.84 1.64 1.66 1.68 1.71 1.75 1.80 1.80 1.82 1.52 1.54 1.48 1.51 1.50 1.51 1.91

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $437,148K ÷ $155,214K
= 2.82

The financial leverage ratio of Mesa Laboratories Inc has shown variability over the periods provided. From March 31, 2020, to December 31, 2022, the ratio remained relatively stable, fluctuating between 1.48 and 1.82. However, a significant increase was observed in the ratio as of March 31, 2024, reaching a high of 3.07, indicating a higher level of financial leverage. Subsequently, the ratio decreased in the following periods but remained elevated compared to the earlier years. Overall, the trend suggests that Mesa Laboratories Inc has increased its reliance on debt financing, which may impact its financial risk and flexibility. Further analysis of the company's debt structure and repayment capacity would be beneficial to assess the implications of this shift in leverage.